Veeva Q4 operating income jumps 30% to USD 245.9 million

Reuters
03/05
Veeva Q4 operating income jumps 30% to USD 245.9 million

Veeva reported Q4 FY2026 total revenues of USD 836.0 million (up 16%) and subscription revenues of USD 707.7 million (up 16%). Q4 operating income was USD 245.9 million (up 30%) and net income was USD 244.2 million (up 25%), with fully diluted EPS of USD 1.45; non-GAAP operating income was USD 366.5 million (up 19%) and non-GAAP net income was USD 346.1 million (up 20%), with non-GAAP fully diluted EPS of USD 2.06. For FY2026, Veeva posted total revenues of USD 3.2 billion (up 16%) and subscription revenues of USD 2.7 billion (up 17%). FY operating income was USD 916.4 million (up 33%) and net income was USD 908.9 million (up 27%), with fully diluted EPS of USD 5.44; non-GAAP operating income was USD 1.4 billion (up 24%) and non-GAAP net income was USD 1.4 billion (up 24%), with non-GAAP fully diluted EPS of USD 8.10. In business updates, Veeva ended the year with 1,552 customers, including 1,196 in R&D and Quality Solutions and 767 in Commercial Solutions, and said it achieved a USD 3 billion revenue run rate in early 2025. The company highlighted progress with Veeva AI Agents for CRM and commercial content, with several customers live and more projects underway, and said it expects to release additional agents across other major application areas throughout 2026. Veeva also reported Vault CRM adoption with more than 125 customers live, 10 of the top 20 biopharmas committed globally, and expects about 14 of the top 20 to commit; it also cited momentum in Development Cloud and Quality Cloud, including a top 20 biopharma selecting Veeva RTSM as its enterprise standard and progress toward a first top 20 biopharma go-live for Veeva LIMS at two manufacturing sites in 2026. For outlook, Veeva guided Q1 FY2027 total revenues of USD 855 million to USD 858 million and updated FY2027 total revenues guidance to USD 3.6 billion to USD 3.6 billion, alongside non-GAAP operating income of about USD 1.6 billion and non-GAAP fully diluted EPS of approximately USD 8.85.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Veeva Systems Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001393052-26-000007), on March 04, 2026, and is solely responsible for the information contained therein.

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10